Trials / Withdrawn
WithdrawnNCT04524715
LLLT Treatment of Lung Inflammation in COVID-19
Low-Level Laser Therapy Treatment of Lung Inflammation in COVID-19 Patients
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Ward Photonics LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine if a reduction of pneumonic inflammation occurs after treatment with Low-Level Laser Therapy (LLLT) applying red-light technology in the respiratory system of COVID-19 patients suffering from acute viral pneumonia.
Detailed description
This clinical trial is a blinded before and after comparison of the effect on patients treated with a red-light LLLT therapy for acute lung inflammation as a result of COVID-19 infection. Patients are enrolled to undergo LLLT therapy in addition to all standard ongoing therapies for COVID-19. Outcomes for patients receiving LLLT in addition to their standard care (the treatment group) are compared to the group receiving only standard therapy for COVID-19 (control group). Effects of LLLT treatment are measured immediately following treatment, and outcome measurements are compared to the pre-treatment baseline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Non-invasive red LLLT treatment to chest of patient. | Expose patient to LLLT light while lying on their back, elevated at an angle of approximately 45 degrees from horizontal. Position light over the patient's chest at a 33-degree bias to their right and left sides for 20 minutes each side respectively. |
| DEVICE | Sham Device Treatment | Expose patient to sham device while lying on their back, elevated at an angle of approximately 45 degrees from horizontal. Position light over the patient's chest at a 33-degree bias to their right and left sides for 20 minutes each side respectively. |
Timeline
- Start date
- 2021-07-31
- Primary completion
- 2022-03-31
- Completion
- 2022-03-31
- First posted
- 2020-08-24
- Last updated
- 2022-07-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04524715. Inclusion in this directory is not an endorsement.